Evidence map›Paper›PMID 38055058›Full record

ArticleMikrochimica acta2023

Water-stable hydrophilic metal organic framework composite for the recognition of N-glycopeptides during diabetes progression by mass spectrometry.

Shuangshuang Liu, Yang Wang, Lingxiao Weng, Jiaqi Wu, Qiuhong Man, Yan Xia, Li-Hao Huang

Abstract read
PubMed Publisher
In one paragraph

Article in Mikrochimica acta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shuangshuang LiuShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200438, China.
Yang WangDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China.
Lingxiao WengDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China.
Jiaqi WuShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200438, China.
Qiuhong ManDepartment of Clinical Laboratory, Shanghai Fourth People's Hospital, Tongji University, Shanghai, 200434, China. Manqiuhong307@163.com.
Yan XiaDepartment of Chemistry and Institutes of Biomedical Sciences, Fudan University, Shanghai, 200438, China. jyxiayan@nbt.edu.cn.
Li-Hao HuangShanghai Key Laboratory of Metabolic Remodeling and Health, Institute of Metabolism and Integrative Biology, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai, 200438, China. lihao_huang@fudan.edu.cn.ORCID http://orcid.org/0000-0002-9868-8709

Funding

the National Natural Science Foundation of China 32171168the National Natural Science Foundation of China 52003056the Scientific Research Foundation of NingboTech University 20220920Z0221
6 · The paper itself

Abstract

A hydrophilic Al-MOFs composite was prepared using cheap and available reagents in water via a suitable large-scale production, an economical and environment-friendly method for capturing N-glycopeptides. The prepared Al-MOFs composite with high hydrolytically stable and hydrophilic 1D channels exhibits an ultralow detection limit (0.5 fmol/μL), and excellent reusability (at least 10 cycles) in the capture of N-glycopeptides from standard bio-samples. Interestingly, the Al-MOFs composite also shows remarkable performance in practical applications, where 300 N-glycopeptides ascribed to 124 glycoproteins were identified in 1 µL human serum and were successfully applied in profiling the differences of N-glycopeptides during diabetes progression. Moreover, 12 specific glycoproteins used as biomarkers to accurately distinguish the progression of diabetes are identified. The present work provides a potential commercial method for large-scale glycoproteomics research in complex clinical samples while offering new guidance for the precise diagnosis of diabetes progression.

Indexed as

Diabetes MellitusMetal-Organic FrameworksGlycopeptidesGlycoproteinsHumansMass SpectrometryWaterGlycopeptidesGlycoproteinsMetal-Organic FrameworksWaterDiabetes progressionGlycopeptides recognitionHuman serumHydrophilic interactionLC-MS/MSMetal–organic frameworksSize exclusionSolid-phase extraction

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.